Published in Medicine and Law Weekly, January 19th, 2007
This trend article about Aarhus University, Denmark, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Investigators publish new data in the report "A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium. Both pemetrexed and gemcitabine have single-agent activity in bladder cancer, but the combination of these two drugs has not been previously evaluated for safety and efficacy in this disease. Thus, the objectives in the current study were to determine overall...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly